In the News

Share
1669 News Items found
Vivian Moore
How MSK Treats Patients 65 and Older With Breast Cancer
The risk of breast cancer increases as you age. MSK has breast cancer experts with special training and experience treating older patients.
Neil Iyengar, medical oncologist at Memorial Sloan Kettering, is seen holding a piece of fruit.
Breast Cancer, Food, and Diet: Tips From an MSK Expert
Learn diet and food tips that can lower the risk of breast cancer and potentially improve the outcome if cancer is diagnosed, from Neil Iyengar, an expert on diet and cancer at Memorial Sloan Kettering.
sperm maturation in the fly testis
Rumble in the Genome: Unlocking the Secrets of the Tiny RNAs That Keep Self-Serving, Harmful Genes in Check
The common wisdom is that genes are preserved from generation to generation because they help the organism survive and reproduce. But MSK's Dr. Eric Lai’s team is showing — in fruit flies — that certain genes can threaten a species’ very survival by pursuing their narrow self-interests in passing along their own genetic material.
MaryAnn Morrison and husband, John.
FDA Approves Elranatamab for Resistant Multiple Myeloma
Learn about a new multiple myeloma drug that can stop the disease after other treatments have failed.
MSK researcher in a lab
MSK Research Highlights, August 24, 2023
New MSK research suggests a method for revealing DNA repair “scars” could help make treatment decisions in BRCA1- and BRCA2-deficient cancers; modified a bacteria-made compound to target mutant KRAS-driven cancers; and shed new light on brain metastasis in non-small cell lung cancer.
ContactTracing graphic
New Research Shows How Cancer Rewires a Key Immune Pathway To Spread
A collaboration between MSK and Weill Cornell Medicine discovered a new relationship between cancer cells and the immune system, and shows how cancer can selfishly hijack a normally helpful immune pathway.
MSK researchers Kayvan Keshari, PhD, and Daniel Heller, PhD
MSK’s New Cancer Engineering PhD Program Is First of Its Kind
Learn about MSK’s visionary new cancer engineering PhD Program.
Medical oncologist Saad Usmani, who specializes in treating multiple myeloma.
Multiple Myeloma: Improved Prognosis With the Latest Treatments
Learn how multiple myeloma prognosis has improved significantly with the emergence of new drug treatments.
Kelly Spill is seen outdoors holding her newborn and talking with Dr. Andrea Cercek of Memorial Sloan Kettering Cancer Center.
The Rectal Cancer Clinical Trial at MSK That Changed Everything for Its Patients
Learn how a heralded clinical trial that made rectal cancer disappear for every participant is being expanded at Memorial Sloan Kettering Cancer Center. The trial uses only immunotherapy that targets a rare mutation — without the need for surgery, chemotherapy, or radiation.
An MSK patient gets a vaccination from a healthcare provider
What To Know About the RSV Vaccines: Who Can Get It, Side Effects, Availability at MSK
RSV is a respiratory illness that spreads in the fall and winter months. Learn about the RSV vaccines, which are approved for people age 60 and older.
Chi Nguyen
2023 GSK Chairman’s Prize Recognizes Chi Nguyen, Research on Gut Health
The 2023 GSK Chairman’s Prize recognizes Chi Nguyen for research on gut health.
An MSK research notebook on a bench in a lab
MSK Research Highlights, August 10, 2023
New MSK research finds a potential target against neuroendocrine transformation in lung and prostate cancers; discovers new clues about why donor T cells attack certain tissues in graft-versus-host disease; sheds light on why T cells let go of their prey; and uses CRISPR interference and dynamic cell-state transitions to discover enhancers that affect early human development.
First-time blood donor
Giving Blood to Help People With Cancer: Tips from a First-Time Donor
Discover how easy it is to donate blood — and the real impact your donation makes.
Drs. Danielle Rochlin and Babek Mehrara
MSK Research Aims to Better Predict and Prevent Lymphedema After Breast Cancer Surgery
Doctors and nurses with Memorial Sloan Kettering’s Plastic and Reconstructive Surgical Service have developed new, simplified models to better predict and prevent breast cancer-related lymphedema.
MSK scientist Britta Weigelt and MSK physician-scientist Sarah Kim
New Progress Using Liquid Biopsies to Analyze cfDNA for Endometrial and Cervical Cancers
Learn how MSK’s liquid biopsy test, MSK-ACCESS, could improve the lives of patients with gynecologic cancers.
Through-the-microscope view of a tissue sample
MSK Research Highlights, July 17, 2023
New MSK research identified a way to reduce toxicity in CAR T cell therapy; discovered a division of labor in DNA repair that suggests a possible therapeutic strategy for certain cancers; developed a new method to enable imaging of two PET tracers simultaneously; found biomarkers that could help predict outcomes in HER2-positive metastatic esophagogastric cancer; and made progress toward improving options for patients with early-stage, potentially indolent cancers.
Once a patient, Jillian is now a breast cancer care coordinator. She shares a love story, a viral video and a special connection to the people of MSK Monmouth.
It’s Personal for Jillian Allegretti, of MSK Monmouth
Once a patient, Jillian is now a breast cancer care coordinator. She shares a love story, a viral video and a special connection to the people of MSK Monmouth.
Selwyn M. Vickers, MD, FACS
A Message From MSK’s President and CEO, Dr. Selwyn Vickers
In cancer care, firsts make a difference. At MSK, we are constantly improving how we help people with those important firsts. Dr. Selwyn Vickers writes about the latest developments at MSK and the encouraging evidence that we are making progress in our mission of ending cancer for life.
Michael Berger, PhD, Co-Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology and Elizabeth and Felix Rohatyn Chair for Junior Faculty
Exposing a Cancer Cell’s Weakness
MSK has developed an arsenal of tests that are at the front lines of precision treatments. They target the structure of proteins that cause cancer, offering people new hope.
Dr. Sohrab Shah
Fighting Cancer With Computers, Math, and Artificial Intelligence
MSK Drs. Larry Norton, Dana Pe’er, and Sohrab Shah know cancer research isn’t all beakers and test tubes — computers and algorithms are some of the most powerful tools in cancer research.